Msl Temporal Oncología - Madrid, España - Johnson & Johnson

Johnson & Johnson

Empresa verificada

Madrid, España

hace 2 semanas

Publicado por:

Isabel García

beBee Recruiter

Descripción

For more than 130 years, diversity, equity & inclusion (DEI) have been part of our cultural fabric at Johnson & Johnson and woven into how we do business every day.

Our commitment to respect the dignity and diversity of all is embedded in our Credo. _

We know that the success of our business depends on having the best talent in a workforce that reflects the diverse markets we serve around the world and an inclusive culture that values different perspectives and life experiences _
That is why we in Spain are working to create an inclusive environment where diverse backgrounds, perspectives and experiences are valued and each and every one of our people feels that they belong and can reach their potential. No matter who they are. _
Diversity, Equity & Inclusion at Johnson & Johnson means "You Belong" _
To maximize company product value through high scientific quality communication with Leading Specialists on a peertopeer basis. Accordingly, to strategic lines of Medical Affairs Plan, the MSL is jointly responsible for achieving shortterm and longterm company goals at local level. _
To be a therapeutic area scientific expert, responsible for discussing our products, patients' treatment trends and studies in the therapeutic areas in which we are involved, on a peertopeer basis with a defined audience of Leading Specialists (Physicians, Pharmacists, Hospital Managers, Board Members of Scientific Societies, and other stakeholders) and to be considered an internal and external trusted scientific counterpart. _

MSLs should have their own Activity Plan and personal objectives. The Individual Activity Plans must be based on the MSLs Country Activity Plan, which is aligned with the Medical Affairs Component of the relevant Brand Plans

To keep abreast of
medical and scientific knowledge.
Continuous update on products, patient's treatment trends, clinical activities and studies conducted within the therapeutic area in their region.
Development and maintenance of a
contact network with Leading Specialists .
Understand their needs, key value drivers, practical treatment patterns and scientific activities within therapeutic area
Communicate value of company products, incl. clinical questionnaire discussions
Through scientific interactions, communicate medical benefits of products and contribute to foster innovative approaches
Represent the company within professional associations in the therapeutic area in cooperation with Medical Affairs/ Medical Education and other positions in the Medical Affairs Department
Proactive and reactive
communication of medical scientific data according to following criteria
Proactive Scientific Communication to Leading Specialists must be consistent with the last approved Summary of Product Characteristics regarding the safe and effective use of approved products in approved indications. Content of Scientific Communication should be highly scientific, accurate, fair and objective, based on an uptodate evaluation of all relevant evidence and reflect that evidence clearly, using neither marketing claims nor brand name.
In some very specific circumstances, the MSL can interact proactively with nonLeading Specialists. The program should be clearly defined in the MSL Country Activity Plan, providing the rational, the objective, content, timelines and selection criteria of the HCPs to be involved.
Description of R&D programs and discussing regulatory developments with no promotional intent are also part of Scientific Communication.
Reactive Communication of medical scientific data can be provided upon request to any Health Care Professional, within the approved label or offlabel. The request should come either directly from the HCP or via the Medical Information department. MSLs are required to document all offlabel information requests they receive from Leading Specialists and other HCPs that they may interact with
Organization and participation in
Medical Education activities, at local &/regional level:
Identify/support/educate speakers
Build Medical Education programs with scientific third party
Collaborate with Medical Education manager in National Medical education activities
Provide scientific material under request. MSLs may initiate discussion with potential speakers, discussing documents/ slides which may be of help for future presentations.
Organization and participation in
Advisory Boards in cooperation with Medical Affairs/Medical Education/other positions in the Medical Affairs Department.

-
Market Access Discussions

MSLs can present highly scientific, accurate, fair and objective data to Payors (Hospital Formulary Committees, Health Insurers, Health Technology Assessment Committees, etc) to provide them with objective information about Company products.

- **Pre